Dr Reddys to sell its rights of anti-cancer agent to Citius Pharma; Stock under pressure

Share
AuthorPosted at
The company has entered into a definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox).

from India Infoline News Service https://ift.tt/3kZaWO0
Post a Comment
Labels

Comments